Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kevin B Kim. (2015) Nivolumab in the treatment of advanced melanoma. Expert Opinion on Orphan Drugs 3:8, pages 945-956.
Read now
Read now
Andrés E. Rossini, Maria A. Dagrosa, Agustina Portu, Giselle Saint Martin, Silvia Thorp, Mariana Casal, Aimé Navarro, Guillermo J. Juvenal & Mario A. Pisarev. (2015) Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines. International Journal of Radiation Biology 91:1, pages 81-89.
Read now
Read now
Jiezhong Chen, Renfu Shao, Xu Dong Zhang & Chen Chen. (2013) Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics. International Journal of Nanomedicine 8, pages 2677-2688.
Read now
Read now
Articles from other publishers (8)
Periklis Kyriazis, Abhinav Tiwary, Jonathan Freeman, Daniel Landry & Gregory Braden. (2021) Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report. Journal of Medical Case Reports 15:1.
Crossref
Crossref
Joanna Mangana, Phil F. Cheng, Corina Kaufmann, Valerie C. Amann, Anna L. Frauchiger, Viola Stögner, Ulrike Held, Roger von Moos, Olivier Michielin, Ralph P. Braun, Mitchell P. Levesque, Simone M. Goldinger & Reinhard Dummer. (2017) Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma Research 27:4, pages 358-368.
Crossref
Crossref
Shelley Ji Eun Hwang, Giuliana Carlos, Deepal Wakade, Karen Byth, Benjamin Y. Kong, Shaun Chou, Matteo S. Carlino, Richard Kefford & Pablo Fernandez-Penas. (2016) Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort. Journal of the American Academy of Dermatology 74:3, pages 455-461.e1.
Crossref
Crossref
J. Chen & X.D. Zhang. 2016. Nanoscience in Dermatology. Nanoscience in Dermatology
189
201
.
Isabella C. Glitza, Dae Won Kim, Young Kwang Chae & Kevin B. Kim. 2016. Genetics of Melanoma. Genetics of Melanoma
237
265
.
Letizia Porcelli, Gabriella Guida, Anna E Quatrale, Tiziana Cocco, Letizia Sidella, Immacolata Maida, Rosa M Iacobazzi, Anna Ferretta, Diana A Stolfa, Sabino Strippoli, Stefania Guida, Stefania Tommasi, Michele Guida & Amalia Azzariti. (2015) Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy. Journal of Translational Medicine 13:1.
Crossref
Crossref
Li Liu, Patrick A. Mayes, Stephen Eastman, Hong Shi, Sapna Yadavilli, Tianqian Zhang, Jingsong Yang, Laura Seestaller-Wehr, Shu-Yun Zhang, Chris Hopson, Lyuben Tsvetkov, Junping Jing, Shu Zhang, James Smothers & Axel Hoos. (2015) The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. Clinical Cancer Research 21:7, pages 1639-1651.
Crossref
Crossref
Gabriel Gazzé. (2015) Pharmacist's role in optimizing therapy of the newer agents for the treatment of metastatic melanoma. Melanoma Management 2:1, pages 75-82.
Crossref
Crossref